Trial Profile
Effect of Pegylated Interferon plus Ribavirin treatment in hepatitis C patients with HIV infection or not infected
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b/ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 12 Dec 2015 New trial record